Indications and Early Outcomes for Total Pancreatectomy at a High-Volume Pancreas Center

Table 1

Summary of data related to the four groups of patients who underwent total pancreatectomy (TP).

Group	Number [%]	Operative time [min]	Blood loss [mL]	RBC units	Stay [days]	Mortality [%]
(1) Tumors	23 (36.5%)	450 (360–750)	800 (300–2500)	0 (0–18)	20 (12–89)	3/23 (13%)
(2) Technical reasons	18 (28.6%)	445 (320–535)	600 (300–2200)	0 (0–4)	21 (10–108)	0/18 (0%)
(3) Troubles	15 (23.8%)	210 (120–525)	1500 (500–3000)	15 (0–34)	48 (22–90)	7/15 (47%)
(4) Therapy-refractory pancreatitis	7 (11.1%)	430 (350–480)	600 (300–2000)	0 (0–2)	15 (7–30)	0/7 (0%)
Median (min–max range) for all 63 patients:		420 (120–750)	800 (300–3000)	0 (0–34)	21 (7–108)	10/63 (15.9%)
Median (min–max range) for elective TP (48 patients):		440 (320–750)	800 (300–2500)	0 (0–18)	24 (11–109)	3/48 (6,25%)

∗For all parameters data are presented as median values with minimum-maximum range.